[HTML][HTML] Targeting transcription factors for therapeutic benefit in rheumatoid arthritis
T Balendran, K Lim, JA Hamilton… - Frontiers in …, 2023 - frontiersin.org
Rheumatoid arthritis (RA) is a destructive inflammatory autoimmune disease that causes
pain and disability. Many of the currently available drugs for treating RA patients are aimed …
pain and disability. Many of the currently available drugs for treating RA patients are aimed …
Targeting transcription factors for therapeutic benefit in rheumatoid arthritis.
T Balendran, K Lim, JA Hamilton… - Frontiers in …, 2023 - europepmc.org
Rheumatoid arthritis (RA) is a destructive inflammatory autoimmune disease that causes
pain and disability. Many of the currently available drugs for treating RA patients are aimed …
pain and disability. Many of the currently available drugs for treating RA patients are aimed …
Targeting transcription factors for therapeutic benefit in rheumatoid arthritis
T Balendran, K Lim, JA Hamilton… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Rheumatoid arthritis (RA) is a destructive inflammatory autoimmune disease that causes
pain and disability. Many of the currently available drugs for treating RA patients are aimed …
pain and disability. Many of the currently available drugs for treating RA patients are aimed …
[HTML][HTML] Targeting transcription factors for therapeutic benefit in rheumatoid arthritis
T Balendran, K Lim, JA Hamilton… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Rheumatoid arthritis (RA) is a destructive inflammatory autoimmune disease that causes
pain and disability. Many of the currently available drugs for treating RA patients are aimed …
pain and disability. Many of the currently available drugs for treating RA patients are aimed …